File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical practice guidelines for the management of adult diffuse gliomas

TitleClinical practice guidelines for the management of adult diffuse gliomas
Authors
KeywordsChemoradiation
Immune therapy
Molecular diagnostics
Surgery
Target therapy
Issue Date2021
Citation
Cancer Letters, 2021, v. 499, p. 60-72 How to Cite?
AbstractTo follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro‐Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for limiting unnecessary treatments and cost. The recommendations focus on molecular and pathological diagnostics, and the main treatment modalities of surgery, radiotherapy, and chemotherapy. In this guideline, we also integrated the results of some clinical trials of immune therapies and target therapies, which we think are ongoing future directions. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China and other countries.
Persistent Identifierhttp://hdl.handle.net/10722/324957
ISSN
2023 Impact Factor: 9.1
2023 SCImago Journal Rankings: 2.595
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorJiang, Tao-
dc.contributor.authorNam, Do Hyun-
dc.contributor.authorRam, Zvi-
dc.contributor.authorPoon, Wai sang-
dc.contributor.authorWang, Jiguang-
dc.contributor.authorBoldbaatar, Damdindorj-
dc.contributor.authorMao, Ying-
dc.contributor.authorMa, Wenbin-
dc.contributor.authorMao, Qing-
dc.contributor.authorYou, Yongping-
dc.contributor.authorJiang, Chuanlu-
dc.contributor.authorYang, Xuejun-
dc.contributor.authorKang, Chunsheng-
dc.contributor.authorQiu, Xiaoguang-
dc.contributor.authorLi, Wenbin-
dc.contributor.authorLi, Shaowu-
dc.contributor.authorChen, Ling-
dc.contributor.authorLi, Xuejun-
dc.contributor.authorLiu, Zhixiong-
dc.contributor.authorWang, Weimin-
dc.contributor.authorBai, Hongmin-
dc.contributor.authorYao, Yu-
dc.contributor.authorLi, Shouwei-
dc.contributor.authorWu, Anhua-
dc.contributor.authorSai, Ke-
dc.contributor.authorLi, Guilin-
dc.contributor.authorYao, Kun-
dc.contributor.authorWei, Xinting-
dc.contributor.authorLiu, Xianzhi-
dc.contributor.authorZhang, Zhiwen-
dc.contributor.authorDai, Yiwu-
dc.contributor.authorLv, Shengqing-
dc.contributor.authorWang, Liang-
dc.contributor.authorLin, Zhixiong-
dc.contributor.authorDong, Jun-
dc.contributor.authorXu, Guozheng-
dc.contributor.authorMa, Xiaodong-
dc.contributor.authorZhang, Wei-
dc.contributor.authorZhang, Chuanbao-
dc.contributor.authorChen, Baoshi-
dc.contributor.authorYou, Gan-
dc.contributor.authorWang, Yongzhi-
dc.contributor.authorWang, Yinyan-
dc.contributor.authorBao, Zhaoshi-
dc.contributor.authorYang, Pei-
dc.contributor.authorFan, Xing-
dc.contributor.authorLiu, Xing-
dc.contributor.authorZhao, Zheng-
dc.contributor.authorWang, Zheng-
dc.contributor.authorLi, Yiming-
dc.contributor.authorWang, Zhiliang-
dc.contributor.authorLi, Guanzhang-
dc.contributor.authorFang, Shengyu-
dc.contributor.authorLi, Lianwang-
dc.contributor.authorLiu, Yanwei-
dc.contributor.authorLiu, Shuai-
dc.contributor.authorShan, Xia-
dc.contributor.authorLiu, Yuqing-
dc.contributor.authorChai, Ruichao-
dc.contributor.authorHu, Huimin-
dc.contributor.authorChen, Jing-
dc.contributor.authorYan, Wei-
dc.contributor.authorCai, Jinquan-
dc.contributor.authorWang, Hongjun-
dc.contributor.authorChen, Lingchao-
dc.contributor.authorYang, Yuan-
dc.contributor.authorWang, Yu-
dc.contributor.authorHan, Lei-
dc.contributor.authorWang, Qixue-
dc.date.accessioned2023-02-27T07:28:33Z-
dc.date.available2023-02-27T07:28:33Z-
dc.date.issued2021-
dc.identifier.citationCancer Letters, 2021, v. 499, p. 60-72-
dc.identifier.issn0304-3835-
dc.identifier.urihttp://hdl.handle.net/10722/324957-
dc.description.abstractTo follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro‐Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for limiting unnecessary treatments and cost. The recommendations focus on molecular and pathological diagnostics, and the main treatment modalities of surgery, radiotherapy, and chemotherapy. In this guideline, we also integrated the results of some clinical trials of immune therapies and target therapies, which we think are ongoing future directions. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China and other countries.-
dc.languageeng-
dc.relation.ispartofCancer Letters-
dc.subjectChemoradiation-
dc.subjectImmune therapy-
dc.subjectMolecular diagnostics-
dc.subjectSurgery-
dc.subjectTarget therapy-
dc.titleClinical practice guidelines for the management of adult diffuse gliomas-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.canlet.2020.10.050-
dc.identifier.pmid33166616-
dc.identifier.scopuseid_2-s2.0-85096585917-
dc.identifier.volume499-
dc.identifier.spage60-
dc.identifier.epage72-
dc.identifier.eissn1872-7980-
dc.identifier.isiWOS:000604424500010-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats